Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities
Net (loss) income	$ (513)	$ 9,300	$ 13,711
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization	24,063	13,295	8,069
Deferred income taxes	(2,981)	(660)	1,638
Stock-based compensation	6,736	3,136	1,994
Non-cash lease expense	2,135	2,497	2,802
Amortization of contract asset	2,058	669	0
Provision for credit losses	268	106	100
Change in operating assets and liabilities
Accounts and other receivables	(24,287)	(14,736)	(8,689)
Prepaid expenses and other current and long-term assets	1,211	1,346	840
Accounts payable	4,766	7,380	14,636
Accrued liabilities	3,400	(44)	2,759
Operating lease liabilities	(1,832)	(2,443)	(2,641)
Contract liabilities	3,299	474	184
Income taxes receivable, net of payable	1,544	(827)	217
Net cash provided by operating activities	19,867	19,493	35,620
Cash flows from investing activities
Business combinations, net of cash and restricted cash acquired	(3,260)	(57,400)	290
Other intangible assets acquired	(280)	(130)	0
Purchases of property and equipment	(1,257)	(979)	(458)
Capitalized internal-use software development costs	(29,763)	(19,300)	(14,389)
Net cash used in investing activities	(34,560)	(77,809)	(15,137)
Cash flows from financing activities
Proceeds from initial public offering, net of underwriter's discounts and commissions	0	224,595	0
Proceeds from private placement	0	50,000	0
Proceeds from repayment of related party loan	0	813	0
Proceeds from exercise of stock-based awards	1,490	315	0
Financial institution funds in-transit	(33,443)	1,984	0
Payments of deferred offering costs	0	(1,961)	0
Payments on other financing obligations	(5,062)	(4,562)	(1,035)
Payments on finance leases	(268)	(272)	(323)
Net cash (used in) provided by financing activities	(37,283)	213,487	(1,358)
Foreign currency effect on cash, cash equivalents and restricted cash	(168)	(8)	114
Net (decrease) increase in cash, cash equivalents and restricted cash	(52,144)	155,163	19,239
Cash and cash equivalents
Beginning of period	201,829	46,666	27,427
End of period	149,685	201,829	46,666
Supplemental disclosure of cash flow information:
Cash paid for income taxes, net of refunds	672	2,487	2,891
Non-cash investing activities:
Property and equipment purchases in accounts payable	81	268	7
Business acquisition liability in accrued liabilities and finance leases and other finance obligations, net of current portion	740	813	0
Non-cash financing activities:
Prepaid insurance funded through short-term borrowings	4,625	5,756	1,389
Issuance of warrant and change in estimate of warrants expected to vest	3,524	4,802	0
Property and equipment acquired through finance lease liabilities	0	0	814
Intangibles acquired through other financing obligations	0	0	55
Cash and Cash Equivalents [Member]
Cash and cash equivalents
Beginning of period	168,386	46,666
End of period	147,334	168,386	46,666
Restricted Cash [Member]
Cash and cash equivalents
Beginning of period	0	0
End of period	2,351	0	0
Restricted Funds Held For Financial Institutions [Member]
Cash and cash equivalents
Beginning of period	33,443	0
End of period	0	33,443	0
Series A Preferred Stock [Member]
Cash flows from financing activities
Redemption of Series A preferred stock	0	(23,013)	0
Payment of dividends on Series A preferred stock	$ 0	$ (34,412)	$ 0
Class A Common Stock [Member]
Non-cash investing activities:
Fair value of Class A common stock issued for acquisitions	0	66,229	0